Yong Song

Second Affiliated Hospital of Nanjing Medical University — China

Medicine · Health Sciences

7h-index207citations20works3.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(8), Lung Cancer Diagnosis and Treatment(6), Lung Cancer Research Studies(6), Cancer Immunotherapy and Biomarkers(3), Cancer Cells and Metastasis(2)

Publications19 total

Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC
Cancer Immunology Immunotherapy·2025· 2 citedOpen Access
Identifying patients who benefit more from perioperative immunotherapy combinations for resectable non-small cell lung cancer based on clinical and molecular characteristics: a meta-analysis of randomized clinical trials
Clinical & Translational Oncology·2024
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer
Cancer Cell·2024· 15 cited
Established the prediction model of early‐stage non‐small cell lung cancer spread through air spaces (STAS) by radiomics and genomics features
Asia-Pacific Journal of Clinical Oncology·2024· 5 citedOpen Access
Safety and Reliability of Urological Telesurgery: A Multi-Center, Single-Blind, Exploratory, Randomized Control Trial
SSRN Electronic Journal·2024Open Access
Toripalimab Plus Chemotherapy for First Line Treatment of Advanced Non-Small Cell Lung Cancer (Choice-01): Final Os and Biomarker Exploration of a Randomized, Double-Blind, Phase 3 Trial
SSRN Electronic Journal·2024Open Access
Comparing the efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis
2023Open Access
International consensus on severe lung cancer—the first edition
Translational Lung Cancer Research·2021· 18 citedOpen Access
Simultaneous in Situ Detection of Protein Expression of Multiple Tumor Markers of CTC and Heteroploid of Chromosome 8 in Primary Lung Cancer
Research Square (Research Square)·2021Open Access
Overexpression of Raf-1 kinase inhibitor protein inhibits cell invasion and migration in lung cancer cells through suppressing epithelial-mesenchymal transition
Translational Cancer Research·2019· 2 citedOpen Access
[China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].
PubMed·2017· 27 citedOpen Access
Prognostic value of Twist in lung cancer: systematic review and meta-analysis.
PubMed·2015· 16 cited
[The management of pulmonary nodules].
PubMed·2015
PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer
Cancer Letters·2015· 90 cited
Medical treatment of advanced non-small cell lung cancer: progress in 2014
Jiefangjun yixue zazhi·2015
Prognostic value of FGFR1 gene copy number in patients with non-small cell lung cancer: a meta-analysis.
PubMed·2014· 22 citedOpen Access
[Lung cancer screening:review and prospect].
PubMed·2014· 1 cited
Single-agent maintenance therapy in non-small cell lung cancer: a systematic review and meta-analysis.
PubMed·2012· 9 cited
[Genomic approaches to tailored therapy in non-small cell lung cancer].
PubMed·2008

Frequent Co-authors

Tangfeng Lv(5), Hongbing Liu(4), Suhua Zhu(3), Wenjun Liang(3), Zhaofeng Wang(3), Yingshui Yao(3), Baohui Han(3), Chuling Li(3), Ranpu Wu(3), Huijuan Li(3), Yunchang Meng(3), Dongmei Yuan(2), Mengzhao Wang(2), Caicun Zhou(2), Yi Hu(2), Junli Zeng(2), Zhijie Wang(2), Bo Zhu(2), Ping Zhan(2), Jiachen Xu(2)